On25 August 2020, 111, Inc., a company dedicated to digitally connecting patients with drugs and healthcare service...
China-based Yiling Pharmaceutical recently issued a notice that it had received a certificate of drug registrati...
Sinopharm Tech Holdings Limited announced that on 1 September 2020, the Group, the Federation of Hong Kong Ind...
Researchers from Hong Kong Baptist University (HKBU) have developed a COVID-19 alert system which will send a ...
Harbour BioMed, a global, clinical-stage, innovative biopharmaceutical company, has launched its newly developed HBICETM...
"6th Annual Biopharma Development and Production Week" conference to be held on 3rd - 5th Novem...
The global company BeiGene, Ltd. and Beijing based Singlomics (Beijing DanXu) Biopharmaceuticals Co., Ltd., ha...
Hong Kong recorded that about 4.8% of men visited their urologist with chronic testicular pain. A new study, led by ...
CStone Pharmaceuticals Co., Ltd. on 31 August 2020 announced that the US Food and Drug Administration (FDA) ha...
China-based Huami Corp. and Huami-USA (HMI), a healthcare services company whose mission is to connect health with ...
China-based HJB, a biologics Contract Development and Manufacturing Organization (CDMO) committed to quality, reliabilit...
Hong Kong-based Sihuan Pharmaceutical Holdings Group Ltd. announced that on 26 August 2020, the Company granted a t...
The market for graft versus host disease (GvHD) prophylaxis and treatment in the five growth markets (5GM*) in the Asia-...
HKBN Enterprise Solutions has announced the launch of innovative, one-stop disinfection solutions to help companies main...
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, has announced it has signed two agreeme...
The 4th China Chongqing (Shizhu) health and wellness conference opened on Aug 22 in Huangshui Town, Shizhu County. At th...
Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Hengrui Therapeutics, Inc. (HTI), a US s...
China-based Ascletis Pharma Inc. recently announced that it completed bridging study of ASC18, the first one-pill, ...
